Newsroom

Press Releases

Saniona Icon blue
November 25, 2021
PRESS RELEASE November 25 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the composition of the Nomination Committee for the Annual General Meeting 2022 . Pursuant to the instruction and charter for the Nomination Committee adopted
November 18, 2021
PRESS RELEASE November 18 , 202 1 Three Months Ended September 30, 2021 (2020) Revenue was SEK 2.3 M (2.2 M) Operating loss was SEK -88.2 M (-37.3 M) Net loss was SEK -93.7 M (-48.3 M) Basic loss per share was SEK -1.50 (-1.14) Diluted loss per share was SEK -1.50 (-1.14) Nine Months Ended
September 15, 2021
PRESS RELEASE 15 September 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Wendy Dwyer as Chief Business Officer. Dwyer has more than 20 years of experience in business development , licensing, and mergers and
August 26, 2021
PRESS RELEASE August 26 , 202 1 Three Months Ended June 30, 2021 (2020) Revenue was SEK 1.9 M (2.0 M) Operating loss was SEK -103.6 M (-26.0 M) Net profit/loss was SEK -103.9 M (-23.9 M) Basic loss per share was SEK -1.67 (-0.81) Diluted loss per share was SEK -1.67 (-0.81) Six Months Ended June
Displaying 1 - 10 of 41